STOCK TITAN
  1. Home
  2. Sec-filings
  3. RDHL
  4. [EFFECT] RedHill Biopharma Ltd. SEC Filing

[EFFECT] RedHill Biopharma Ltd. SEC Filing

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
EFFECT

Rhea-AI Filing Summary

Analyzing...
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date: January 27, 2026 9:00 A.M.
Form: F-1
CIK: 0001553846
Company Name: RedHill Biopharma Ltd.
File Number: 333-292528

Source: View Original Filing on SEC EDGAR

Redhill Biopharm

NASDAQ:RDHL

View RDHL Stock Overview →

RDHL Rankings

#6754 Ranked by Market Cap
N/A Ranked by Dividends

RDHL Latest News

Mar 4, 2026
H. pylori Infections Market in the 6MM to Observe Stupendous Growth at a CAGR of 9.5% During the Forecast Period (2026-2036) | DelveInsight
Feb 25, 2026
Joint U.S. Commercialization of RedHill's Talicia® Commences
Jan 5, 2026
RedHill's RHB-102 Progresses in Multiple GI Indications Including GLP-1 Therapy-Related GI Side Effects
Jan 5, 2026
RedHill's RHB-102 Progresses in Multiple GI Indications Including GLP-1 Therapy-Related GI Side Effects
Dec 15, 2025
RedHill Biopharma's Positive Opaganib Results Indicate Reduction in Venetoclax Resistant Cells

RDHL Latest SEC Filings

Mar 5, 2026
[6-K] RedHill Biopharma Ltd. Current Report (Foreign Issuer)
Feb 25, 2026
[6-K] RedHill Biopharma Ltd. Current Report (Foreign Issuer)
Feb 2, 2026
[424B3] RedHill Biopharma Ltd. Prospectus Filed Pursuant to Rule 424(b)(3)
Jan 27, 2026
[6-K] RedHill Biopharma Ltd. Current Report (Foreign Issuer)
Jan 22, 2026
[F-1/A] RedHill Biopharma Ltd. Amended Foreign Issuer IPO Registration

RDHL Stock Data

4.36M
5.11M
Drug Manufacturers - Specialty & Generic
Healthcare
Link
Israel
Tel Aviv-Yafo